Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Long-Term Asthma Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Long-Term Asthma Drugsmarket, defines the market attractiveness level of Long-Term Asthma Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Long-Term Asthma Drugs industry, describes the types of Long-Term Asthma Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Long-Term Asthma Drugs market and the development prospects and opportunities of Long-Term Asthma Drugs industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Long-Term Asthma Drugs market in Chapter 13.
By Player:
Merck
GlaxoSmithKline
Teva Pharmaceutical
Roche
Vectura Group
Novartis
Pfizer
AstraZeneca
Boehringer Ingelheim
By Type:
Tablet
Spray
By End-User:
Hospital Pharmacy
Online Pharmacy
Retail Pharmacy
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Long-Term Asthma Drugs Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Long-Term Asthma Drugs Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Long-Term Asthma Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Long-Term Asthma Drugs Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Long-Term Asthma Drugs Market Analysis and Outlook to 2022
-
7.1 Global Long-Term Asthma Drugs Consumption (2017-2022)
-
7.2 United States Long-Term Asthma Drugs Consumption (2017-2022)
-
7.3 Europe Long-Term Asthma Drugs Consumption (2017-2022)
-
7.4 China Long-Term Asthma Drugs Consumption (2017-2022)
-
7.5 Japan Long-Term Asthma Drugs Consumption (2017-2022)
-
7.6 India Long-Term Asthma Drugs Consumption (2017-2022)
-
7.7 South Korea Long-Term Asthma Drugs Consumption (2017-2022)
8 Region and Country-wise Long-Term Asthma Drugs Market Analysis and Outlook to 2028
-
8.1 Global Long-Term Asthma Drugs Consumption Forecast (2022-2028)
-
8.2 United States Long-Term Asthma Drugs Consumption Forecast (2022-2028)
-
8.3 Europe Long-Term Asthma Drugs Consumption Forecast (2022-2028)
-
8.4 China Long-Term Asthma Drugs Consumption Forecast (2022-2028)
-
8.5 Japan Long-Term Asthma Drugs Consumption Forecast (2022-2028)
-
8.6 India Long-Term Asthma Drugs Consumption Forecast (2022-2028)
-
8.7 South Korea Long-Term Asthma Drugs Consumption Forecast (2022-2028)
9 Global Long-Term Asthma Drugs Market Outlook by Types and Applications to 2022
-
9.1 Global Long-Term Asthma Drugs Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Tablet Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Spray Consumption and Growth Rate (2017-2022)
-
9.2 Global Long-Term Asthma Drugs Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Pharmacy Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Online Pharmacy Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Retail Pharmacy Consumption and Growth Rate (2017-2022)
10 Global Long-Term Asthma Drugs Market Outlook by Types and Applications to 2028
-
10.1 Global Long-Term Asthma Drugs Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Tablet Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Spray Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Long-Term Asthma Drugs Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Pharmacy Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Online Pharmacy Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Retail Pharmacy Consumption Forecast and Growth Rate (2022-2028)
11 Global Long-Term Asthma Drugs Import and Export Analysis (Top 5 Countries)
-
11.1 Global Long-Term Asthma Drugs Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Long-Term Asthma Drugs Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Long-Term Asthma Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Long-Term Asthma Drugs Market Competitive Analysis
-
14.1 Merck
-
14.1.1 Merck Company Details
-
14.1.2 Merck Long-Term Asthma Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Merck Long-Term Asthma Drugs Product and Service
-
14.2 GlaxoSmithKline
-
14.2.1 GlaxoSmithKline Company Details
-
14.2.2 GlaxoSmithKline Long-Term Asthma Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 GlaxoSmithKline Long-Term Asthma Drugs Product and Service
-
14.3 Teva Pharmaceutical
-
14.3.1 Teva Pharmaceutical Company Details
-
14.3.2 Teva Pharmaceutical Long-Term Asthma Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Teva Pharmaceutical Long-Term Asthma Drugs Product and Service
-
14.4 Roche
-
14.4.1 Roche Company Details
-
14.4.2 Roche Long-Term Asthma Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Roche Long-Term Asthma Drugs Product and Service
-
14.5 Vectura Group
-
14.5.1 Vectura Group Company Details
-
14.5.2 Vectura Group Long-Term Asthma Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Vectura Group Long-Term Asthma Drugs Product and Service
-
14.6 Novartis
-
14.6.1 Novartis Company Details
-
14.6.2 Novartis Long-Term Asthma Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Novartis Long-Term Asthma Drugs Product and Service
-
14.7 Pfizer
-
14.7.1 Pfizer Company Details
-
14.7.2 Pfizer Long-Term Asthma Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Pfizer Long-Term Asthma Drugs Product and Service
-
14.8 AstraZeneca
-
14.8.1 AstraZeneca Company Details
-
14.8.2 AstraZeneca Long-Term Asthma Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 AstraZeneca Long-Term Asthma Drugs Product and Service
-
14.9 Boehringer Ingelheim
-
14.9.1 Boehringer Ingelheim Company Details
-
14.9.2 Boehringer Ingelheim Long-Term Asthma Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Boehringer Ingelheim Long-Term Asthma Drugs Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Long-Term Asthma Drugs
-
Figure Long-Term Asthma Drugs Picture
-
Table Global Long-Term Asthma Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Long-Term Asthma Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Long-Term Asthma Drugs Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Long-Term Asthma Drugs Consumption by Country (2017-2022)
-
Figure United States Long-Term Asthma Drugs Consumption and Growth Rate (2017-2022)
-
Table Europe Long-Term Asthma Drugs Consumption and Growth Rate (2017-2022)
-
Figure China Long-Term Asthma Drugs Consumption and Growth Rate (2017-2022)
-
Figure Japan Long-Term Asthma Drugs Consumption and Growth Rate (2017-2022)
-
Figure India Long-Term Asthma Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Korea Long-Term Asthma Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Long-Term Asthma Drugs Consumption Forecast by Country (2022-2028)
-
Figure United States Long-Term Asthma Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Long-Term Asthma Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Long-Term Asthma Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Long-Term Asthma Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Long-Term Asthma Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Long-Term Asthma Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Tablet Consumption and Growth Rate (2017-2022)
-
Figure Global Spray Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Pharmacy Consumption and Growth Rate (2017-2022)
-
Figure Global Online Pharmacy Consumption and Growth Rate (2017-2022)
-
Figure Global Retail Pharmacy Consumption and Growth Rate (2017-2022)
-
Figure Global Tablet Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Spray Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Pharmacy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Online Pharmacy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Retail Pharmacy Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Long-Term Asthma Drugs Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Long-Term Asthma Drugs Export by Region (Top 5 Countries) (2017-2028)
-
Table Merck (Foundation Year, Company Profile and etc.)
-
Table Merck Long-Term Asthma Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Long-Term Asthma Drugs Product and Service
-
Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline Long-Term Asthma Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Long-Term Asthma Drugs Product and Service
-
Table Teva Pharmaceutical (Foundation Year, Company Profile and etc.)
-
Table Teva Pharmaceutical Long-Term Asthma Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Teva Pharmaceutical Long-Term Asthma Drugs Product and Service
-
Table Roche (Foundation Year, Company Profile and etc.)
-
Table Roche Long-Term Asthma Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Roche Long-Term Asthma Drugs Product and Service
-
Table Vectura Group (Foundation Year, Company Profile and etc.)
-
Table Vectura Group Long-Term Asthma Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Vectura Group Long-Term Asthma Drugs Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Long-Term Asthma Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Long-Term Asthma Drugs Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Long-Term Asthma Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Long-Term Asthma Drugs Product and Service
-
Table AstraZeneca (Foundation Year, Company Profile and etc.)
-
Table AstraZeneca Long-Term Asthma Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Long-Term Asthma Drugs Product and Service
-
Table Boehringer Ingelheim (Foundation Year, Company Profile and etc.)
-
Table Boehringer Ingelheim Long-Term Asthma Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Boehringer Ingelheim Long-Term Asthma Drugs Product and Service
-
